8-K Announcements
6Material company update
May 13, 2026·SEC
Material company update
May 8, 2026·SEC
Material company update
Apr 29, 2026·SEC
Femasys Inc.(FEMY)Earnings, Financials & Key Ratios
FEMY•NASDAQ
Price updated Jun 23, 2026
AboutFemasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.Show more
- Revenue$2M+40.8%
- EBITDA-$17M+1.0%
- Net Income-$19M+1.0%
- EPS (Diluted)-9.40+44.0%
- Gross Margin61.96%-6.9%
- EBITDA Margin-729.87%+29.7%
- Operating Margin-766.95%+29.8%
- Net Margin-812.27%+29.7%
- ROE-455.8%-150.2%
FEMY Key Insights
Femasys Inc. (FEMY) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 17.2%
- ✓Trading at only 1.4x book value
✗Weaknesses
- ✗Profits declining 21.9% over 5 years
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 3 (bottom 3%)
- ✗Shares diluted 77.6% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when FEMY posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
FEMY Price & Volume
Femasys Inc. (FEMY) stock price & volume — 10-year historical chart
Loading chart...
FEMY Growth Metrics
Femasys Inc. (FEMY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years17.18%
3 Years23.88%
TTM39.88%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM41.26%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM64.21%
Return on Capital
10 Years-94.46%
5 Years-94.51%
3 Years-121.62%
Last Year-167.91%
FEMY Recent Earnings
Femasys Inc. (FEMY) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
May 8, 2026Metric
Actual
Est
EPS
$0.00+107.3%
$0.07
Rev
$424,889-44.6%
$767,000
Q2 2026
Mar 31, 2026Metric
Actual
Est
EPS
$0.01+88.0%
$0.08
Rev
$814,313-23.2%
$1M
Q4 2025
Nov 14, 2025Metric
Actual
Est
EPS
$0.10+13.0%
$0.12
Rev
$729,394-46.0%
$1M
Q3 2025
Aug 8, 2025Metric
Actual
Est
EPS
$0.16+11.1%
$0.18
Rev
$409,268-60.1%
$1M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 8, 2026 | $0.00vs $0.07+107.3% | $424,889vs $767,000-44.6% |
| Q2 2026 | Mar 31, 2026 | $0.01vs $0.08+88.0% | $814,313vs $1M-23.2% |
| Q4 2025 | Nov 14, 2025 | $0.10vs $0.12+13.0% | $729,394vs $1M-46.0% |
| Q3 2025 | Aug 8, 2025 | $0.16vs $0.18+11.1% | $409,268vs $1M-60.1% |
Based on last 12 quarters of dataView full earnings history →
FEMY Peer Comparison
Femasys Inc. (FEMY) competitors in Surgical and interventional devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CODA | 106.72M | 9.46 | 25.57 | 30.75% | 17.66% | 8.33% | 0.01 | |
 BLFS | 1.21B | 24.79 | -99.16 | 16.97% | -10.52% | -2.91% | 0.05 | |
 XWEL | 6.64M | 1.09 | -0.21 | -13.83% | -81.35% | -20.01% | ||
 HOLO | 2.39M | 1.64 | -0.26 | 42.62% | 91.92% | 10.3% | 0.00 | |
 SSKN | 824.35K | 0.14 | -0.10 | -8.54% | -21.13% | -360.33% | 5.59 | |
 TELA | 35.18M | 0.79 | -0.95 | 15.84% | -49.3% | -13.44% | 8.82 | |
 NXRT | 692.32M | 27.28 | -21.65 | -3.24% | -12.67% | -10.13% | 5.18 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 11.01% | 0.52 |
Compare FEMY vs Peers
Femasys Inc. (FEMY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
FEMY Income Statement
Femasys Inc. (FEMY) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 929.06K | 1.04M | 1.18M | 1.21M | 1.07M | 1.63M | 2.29M | 2.38M |
Revenue Growth % | - | 11.72% | 13.66% | 2.25% | -11.13% | 51.97% | 40.77% | 39.88% |
Cost of Goods Sold | 223.68K | 306.53K | 370.38K | 441.94K | 380.07K | 544.9K | 872.4K | 1.11M |
COGS % of Revenue | 24.08% | 29.53% | 31.4% | 36.64% | 35.46% | 33.45% | 38.04% | - |
Gross Profit | 705.39K▲ 0% | 731.38K▲ 3.7% | 809.3K▲ 10.7% | 764.28K▼ 5.6% | 691.9K▼ 9.5% | 1.08M▲ 56.7% | 1.42M▲ 31.1% | 1.26M▲ 0% |
Gross Margin % | 75.92% | 70.47% | 68.6% | 63.36% | 64.54% | 66.55% | 61.96% | 53.13% |
Gross Profit Growth % | - | 3.69% | 10.65% | -5.56% | -9.47% | 56.7% | 31.06% | - |
Operating Expenses | 12.34M | 7.66M | 9.15M | 12.36M | 15.2M | 18.87M | 19.01M | 17.61M |
OpEx % of Revenue | 1328.5% | 738.45% | 775.3% | 1025.07% | 1417.98% | 1158.3% | 828.91% | - |
Selling, General & Admin | 4.8M | 2.85M | 4.47M | 5.99M | 7.51M | 10.36M | 11.09M | 11.56M |
SG&A % of Revenue | 516.93% | 275% | 378.98% | 496.56% | 700.41% | 635.69% | 483.57% | - |
Research & Development | 6.91M | 4.13M | 4.08M | 5.81M | 7.21M | 8.22M | 7.58M | 5.92M |
R&D % of Revenue | 744.21% | 397.97% | 346.22% | 481.98% | 672.47% | 504.36% | 330.43% | - |
Other Operating Expenses | 625.78K | 679.65K | 591.07K | 561.23K | 483.48K | 297.32K | 342.03K | 139K |
Operating Income | -11.64M▲ 0% | -6.93M▲ 40.4% | -8.34M▼ 20.2% | -11.6M▼ 39.1% | -14.51M▼ 25.1% | -17.79M▼ 22.6% | -17.59M▲ 1.1% | -16.35M▲ 0% |
Operating Margin % | -1252.57% | -667.99% | -706.7% | -961.71% | -1353.43% | -1091.75% | -766.95% | -687.93% |
Operating Income Growth % | - | 40.42% | -20.25% | -39.15% | -25.07% | -22.59% | 1.11% | - |
EBITDA | -10.54M | -5.83M | -7.37M | -10.71M | -13.6M | -16.91M | -16.74M | -15.52M |
EBITDA Margin % | -1134.75% | -561.93% | -624.95% | -887.99% | -1268.73% | -1038.22% | -729.87% | -652.85% |
EBITDA Growth % | - | 44.68% | -26.41% | -45.28% | -26.97% | -24.36% | 1.04% | 17.98% |
D&A (Non-Cash Add-back) | 1.09M | 1.1M | 964.29K | 889.14K | 907.99K | 872K | 850.46K | 833.85K |
EBIT | -11.26M | -6.9M | -7.51M | -11.37M | -14.08M | -17.2M | -16.74M | -10.27M |
Net Interest Income | 277.56K | 9.95K | -15.46K | 214.7K | 265.63K | -1.02M | -1.79M | -1.48M |
Interest Income | 287.54K | 22.5K | 3.77K | 228.16K | 431.02K | 582.35K | 101.76K | 132.56K |
Interest Expense | 9.97K | 12.55K | 19.23K | 13.46K | 165.39K | 1.6M | 1.89M | 1.61M |
Other Income/Expense | 368.24K | 19.95K | 802.96K | 212.39K | 265.63K | -1.02M | -1.04M | 4.47M |
Pretax Income | -11.27M▲ 0% | -6.91M▲ 38.7% | -7.53M▼ 9.0% | -11.39M▼ 51.2% | -14.24M▼ 25.1% | -18.81M▼ 32.0% | -18.63M▲ 1.0% | -11.88M▲ 0% |
Pretax Margin % | -1212.93% | -666.06% | -638.63% | -944.1% | -1328.66% | -1154.44% | -812.21% | -499.78% |
Income Tax | 3.01K | 1.8K | 4K | 6.3K | 4.34K | 9.6K | 1.3K | 522.94K |
Effective Tax Rate % | -0.03% | -0.03% | -0.05% | -0.06% | -0.03% | -0.05% | -0.01% | -4.4% |
Net Income | -11.27M▲ 0% | -6.91M▲ 38.7% | -7.54M▼ 9.0% | -11.39M▼ 51.2% | -14.25M▼ 25.0% | -18.82M▼ 32.1% | -18.63M▲ 1.0% | -12.4M▲ 0% |
Net Margin % | -1213.26% | -666.24% | -638.97% | -944.62% | -1329.06% | -1155.03% | -812.27% | -521.78% |
Net Income Growth % | - | 38.65% | -9.01% | -51.16% | -25.04% | -32.07% | 1% | 41.26% |
Net Income (Continuing) | -11.27M | -6.91M | -7.54M | -11.39M | -14.25M | -18.82M | -18.63M | -12.4M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -19.20▲ 0% | -11.80▲ 38.5% | -12.80▼ 8.5% | -19.40▼ 51.6% | -18.60▲ 4.1% | -16.80▲ 9.7% | -9.40▲ 44.0% | -3.18▲ 0% |
EPS Growth % | - | 38.54% | -8.47% | -51.56% | 4.12% | 9.68% | 44.05% | 64.21% |
EPS (Basic) | -19.20 | -11.80 | -12.80 | -19.40 | -18.60 | -16.80 | -9.40 | - |
Diluted Shares Outstanding | 588.08K | 588.08K | 590.21K | 590.21K | 769.22K | 1.11M | 1.98M | 3.9M |
Basic Shares Outstanding | 588.08K | 588.08K | 590.21K | 590.21K | 769.22K | 1.11M | 1.98M | 3.33M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
FEMY Balance Sheet
Femasys Inc. (FEMY) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 8.04M | 3.86M | 25.63M | 14.13M | 23.18M | 8.02M | 16.46M | 12.34M |
Cash & Short-Term Investments | 7.41M | 3.32M | 24.78M | 12.96M | 21.72M | 3.45M | 9.27M | 5.39M |
Cash Only | 6.42M | 3.32M | 24.78M | 12.96M | 21.72M | 3.45M | 9.27M | 5.39M |
Short-Term Investments | 998.83K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 83.55K | 125.79K | 84.26K | 77.47K | 98.91K | 488.37K | 616.6K | 172.26K |
Days Sales Outstanding | 32.83 | 44.24 | 26.07 | 23.44 | 33.68 | 109.42 | 98.14 | 62.02 |
Inventory | 172.5K | 131.38K | 208.27K | 436.72K | 667.12K | 3.05M | 5.74M | 6.11M |
Days Inventory Outstanding | 281.48 | 156.44 | 205.24 | 360.69 | 640.67 | 2.04K | 2.4K | 1.87K |
Other Current Assets | 370.02K | 284.12K | 555.85K | 655.36K | 695.88K | 1.04M | 833.13K | 679.92K |
Total Non-Current Assets | 4.61M | 3.74M | 2.95M | 2.76M | 4.58M | 4.42M | 4.27M | 4.15M |
Property, Plant & Equipment | 3.86M | 2.89M | 2.26M | 1.8M | 3.49M | 3.4M | 3.19M | 3.1M |
Fixed Asset Turnover | 0.24x | 0.36x | 0.52x | 0.67x | 0.31x | 0.48x | 0.72x | 0.75x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 160.59K | 65.07K | 25.09K | 3.29K | 0 | 65.92K | 134.91K | 124.25K |
Long-Term Investments | 0 | 0 | -20.38M | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 583.5K | 792.44K | 655.42K | 958.18K | 1.09M | 954.99K | 940.23K | 924.55K |
Total Assets | 12.65M▲ 0% | 7.61M▼ 39.9% | 28.58M▲ 275.7% | 16.9M▼ 40.9% | 27.76M▲ 64.3% | 12.45M▼ 55.2% | 20.72M▲ 66.5% | 16.5M▲ 0% |
Asset Turnover | 0.07x | 0.14x | 0.04x | 0.07x | 0.04x | 0.13x | 0.11x | 0.14x |
Asset Growth % | - | -39.85% | 275.7% | -40.88% | 64.28% | -55.16% | 66.53% | 63.24% |
Total Current Liabilities | 1.29M | 2.89M | 1.69M | 1.53M | 3.05M | 8.58M | 3.64M | 3.16M |
Accounts Payable | 481.1K | 674.33K | 445.52K | 510.76K | 1.14M | 1.42M | 1.83M | 1.6M |
Days Payables Outstanding | 785.06 | 802.95 | 439.05 | 421.84 | 1.09K | 950.54 | 765.7 | 726.04 |
Short-Term Debt | 0 | 630.01K | 181.12K | 141.3K | 0 | 5.41M | 0 | 480.29K |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 32.9K | 54.98K | 416.73K | 1.15M | 88.58K | 923.55K | 324.12K |
Current Ratio | 6.25x | 1.34x | 15.15x | 9.25x | 7.59x | 0.93x | 4.53x | 3.91x |
Quick Ratio | 6.12x | 1.29x | 15.02x | 8.96x | 7.37x | 0.58x | 2.95x | 1.98x |
Cash Conversion Cycle | -470.75 | -602.28 | -207.73 | -37.7 | -418.37 | 1.2K | 1.73K | 1.21K |
Total Non-Current Liabilities | 56.73M | 1.19M | 552.21K | 125.24K | 6.35M | 1.56M | 11.22M | 6.05M |
Long-Term Debt | 0 | 182.49K | 0 | 0 | 4.26M | 0 | 3.18M | 3.34M |
Capital Lease Obligations | 1.24M | 809.09K | 402.42K | 28.58K | 2.04M | 1.52M | 1.03M | 4.36M |
Deferred Tax Liabilities | 0 | 0 | 20.38M | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 55.49M | 197.87K | 149.79K | 96.66K | 54.94K | 39.61K | 7.01M | 1.8M |
Total Liabilities | 58.02M | 4.08M | 2.24M | 1.65M | 9.4M | 10.14M | 14.85M | 9.21M |
Total Debt | 1.71M | 2.06M | 990.21K | 543.72K | 6.7M | 7.44M | 4.7M | 4.73M |
Net Debt | -4.7M | -1.27M | -23.79M | -12.42M | -15.02M | 3.99M | -4.57M | -658.04K |
Debt / Equity | - | 0.58x | 0.04x | 0.04x | 0.37x | 3.23x | 0.80x | 0.65x |
Debt / EBITDA | - | - | - | - | - | - | - | -0.30x |
Net Debt / EBITDA | - | - | - | - | - | - | - | 0.04x |
Interest Coverage | -1129.06x | -549.72x | -390.86x | -844.80x | -85.12x | -10.73x | -8.85x | -6.39x |
Total Equity | -45.37M▲ 0% | 3.53M▲ 107.8% | 26.33M▲ 646.4% | 15.24M▼ 42.1% | 18.35M▲ 20.4% | 2.3M▼ 87.4% | 5.87M▲ 154.7% | 7.29M▲ 0% |
Equity Growth % | - | 107.78% | 646.39% | -42.11% | 20.4% | -87.44% | 154.7% | 309.51% |
Book Value per Share | -77.15 | 6.00 | 44.62 | 25.83 | 23.86 | 2.07 | 2.97 | 1.87 |
Total Shareholders' Equity | -45.37M | 3.53M | 26.33M | 15.24M | 18.35M | 2.3M | 5.87M | 7.29M |
Common Stock | 1.06K | 1.11K | 11.92K | 11.99K | 21.77K | 23.47K | 59.72K | 60.51K |
Retained Earnings | -68.29M | -75.2M | -82.74M | -94.13M | -108.38M | -127.2M | -145.83M | -144.98M |
Treasury Stock | -60K | -60K | -60K | -60K | -60K | -60K | -60K | -60K |
Accumulated OCI | 20 | 702.49K | 702.49K | 567.97K | 2.79M | 1.86M | 0 | 5.25M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
FEMY Cash Flow Statement
Femasys Inc. (FEMY) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | -11.01M | -4.93M | -7.93M | -10.73M | -11.28M | -19.44M | -18.69M | -18.07M |
Operating CF Margin % | -1184.63% | -475.28% | -672.28% | -889.72% | -1052.32% | -1193.54% | -815% | - |
Operating CF Growth % | - | 55.18% | -60.77% | -35.32% | -5.11% | -72.37% | 3.87% | 31.56% |
Net Income | -11.27M | -6.91M | -7.54M | -11.39M | -14.25M | -18.82M | -18.63M | -12.4M |
Depreciation & Amortization | 1.09M | 1.1M | 964.29K | 889.14K | 907.99K | 872K | 804.28K | 833.85K |
Stock-Based Compensation | 358.84K | 318.64K | 193.37K | 224.94K | 675.7K | 444.15K | 790.14K | 574.52K |
Deferred Taxes | 0 | 0 | 3.64K | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | -107.17K | 4.61K | -821.51K | 6.38K | 161.39K | 1.2M | 399.74K | -4.3M |
Working Capital Changes | -1.08M | 557.96K | -732.72K | -458.27K | 1.22M | -3.14M | -2.06M | -2.53M |
Change in Receivables | 3.26K | -42.24K | 41.53K | 6.79K | -21.44K | 8K | -128.23K | 56.33K |
Change in Inventory | -34.73K | 35.32K | -77.43K | -232.55K | -236.28K | -2.38M | -2.69M | -2.24M |
Change in Payables | -13.93K | 80.75K | -228.81K | 65.24K | 627.07K | 207.48K | 334.83K | -809.29K |
Cash from Investing | 12.32M | 968.32K | -306.87K | -407.48K | -143.92K | -847.76K | -630.1K | -612.63K |
Capital Expenditures | -696.5K | -8.35K | -306.87K | -407.48K | -143.92K | -761.71K | -525.01K | -612.63K |
CapEx % of Revenue | 74.97% | 0.8% | 26.01% | 33.78% | 13.43% | 46.76% | 22.89% | 25.77% |
Acquisitions | 103.14K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - |
Other Investing | -103.14K | -23.33K | 0 | 0 | 0 | -86.06K | -105.09K | 0 |
Cash from Financing | -127.78K | 871.65K | 29.7M | -681.64K | 20.18M | 2.03M | 25.14M | 20.25M |
Debt Issued (Net) | -113.33K | 793.45K | -462.95K | -505.2K | 6.22M | 0 | 4.15M | 3.22M |
Equity Issued (Net) | 2.63K | 153.2K | 31.74M | 59.58K | 11.56M | 2.03M | 22.93M | 17.03M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -17.07K | -75K | -1.58M | -236.02K | 2.39M | 2.35K | -1.95M | 0 |
Net Change in Cash | 1.18M▲ 0% | -3.09M▼ 361.3% | 21.46M▲ 793.8% | -11.82M▼ 155.1% | 8.75M▲ 174.1% | -18.26M▼ 308.6% | 5.81M▲ 131.8% | 1.57M▲ 0% |
Free Cash Flow | -11.7M▲ 0% | -4.96M▲ 57.6% | -8.24M▼ 65.9% | -11.14M▼ 35.2% | -11.42M▼ 2.6% | -20.21M▼ 76.9% | -19.22M▲ 4.9% | -18.58M▲ 0% |
FCF Margin % | -1259.6% | -478.33% | -698.29% | -923.5% | -1065.74% | -1240.29% | -837.9% | -781.53% |
FCF Growth % | - | 57.58% | -65.92% | -35.23% | -2.56% | -76.86% | 4.9% | 9.36% |
FCF per Share | -19.90 | -8.44 | -13.96 | -18.87 | -14.85 | -18.15 | -9.72 | -4.76 |
FCF Conversion (FCF/Net Income) | 0.98x | 0.71x | 1.05x | 0.94x | 0.79x | 1.03x | 1.00x | 1.50x |
Interest Paid | 0 | 8.9K | 15.87K | 13.46K | 9.9K | 111K | 8.62K | 0 |
Taxes Paid | 0 | 0 | 800 | 5.05K | 4.55K | 5.71K | 6.81K | 800 |
FEMY Key Ratios
Femasys Inc. (FEMY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -196.01% | -50.49% | -54.81% | -84.82% | -182.18% | -455.8% | -258.08% |
Return on Invested Capital (ROIC) | -229.94% | -260.47% | -324.4% | -353.19% | -276.97% | -347.38% | -218.14% |
Gross Margin | 70.47% | 68.6% | 63.36% | 64.54% | 66.55% | 61.96% | 53.13% |
Net Margin | -666.24% | -638.97% | -944.62% | -1329.06% | -1155.03% | -812.27% | -521.78% |
Debt / Equity | 0.58x | 0.04x | 0.04x | 0.37x | 3.23x | 0.80x | 0.65x |
Interest Coverage | -549.72x | -390.86x | -844.80x | -85.12x | -10.73x | -8.85x | -6.39x |
FCF Conversion | 0.71x | 1.05x | 0.94x | 0.79x | 1.03x | 1.00x | 1.50x |
Revenue Growth | 11.72% | 13.66% | 2.25% | -11.13% | 51.97% | 40.77% | 39.88% |
Related:FEMY Dividend History·FEMY Revenue History·FEMY Price History·FEMY P/E History·FEMY Financial Ratios·FEMY Institutional Holders
FEMY SEC Filings & Documents
Femasys Inc. (FEMY) SEC filings — annual & quarterly reports (10-K, 10-Q)
FEMY Frequently Asked Questions
Femasys Inc. (FEMY) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Femasys Inc. (FEMY) reported $2.4M in revenue for fiscal year 2025. This represents a 156% increase from $0.9M in 2019.
Femasys Inc. (FEMY) grew revenue by 40.8% over the past year. This is strong growth.
Femasys Inc. (FEMY) reported a net loss of $12.4M for fiscal year 2025.
Dividend & Returns
Femasys Inc. (FEMY) has a return on equity (ROE) of -455.8%. Negative ROE indicates the company is unprofitable.
Femasys Inc. (FEMY) had negative free cash flow of $18.6M in fiscal year 2025, likely due to heavy capital investments.